Paper - WANFANG MED ONLINE

You Position: Home > Paper

放射治疗中食管癌原发肿瘤靶区位移及其影响

( views:368, downloads:208 )

Author:: No author available

Journal Title:: Chinese Journal of Oncology

Issue:: 8

DOI:: 10.3760/cma.j.issn.0253-3766.2013.08.001

Key Word:: 食管肿瘤;放射疗法;靶区位移;影响

Abstract：放射治疗是食管癌非手术治疗的重要组成部分,以三维适形放疗(three-dimensional conformal radiotherapy,3D-CRT)和调强放疗(intensity modulated radiotherapy,IMRT)为主的精确放疗现已成为食管癌放疗的主流技术.靶区的确定与修正是食管癌精确放疗的关键环节,而靶区位移的确定则是食管癌计划靶区(planning target volume,PTV)确定与修正的重要依据.目前,食管癌原发肿瘤靶区位移及其影响备受关注.

Reference

[1]洪金省,张纬建,陈金梅,等.胸段食管癌三维适形放疗摆位误差研究[J].2009,(3).
[2]杨福俊,张健,李洪升,等.四维CT测量平静呼吸下原发胸段食管肿瘤运动的初步研究[J].2011,(3).
[3]王奇峰,章文成,陈辛元,等.食管癌简化调强放疗中靶体积变化及对初始计划剂量学影响[J].2010,(6).
[4]霍俊杰,乔学英,周志国,等.食管胸中段癌三维适形放疗中呼吸运动导致靶区剂量学变化的研究[J].2010,(6).
[5]张英杰,李建彬,王玮,等.基于四维CT的食管癌整体与分层测量内边界外扩距离的比较研究[J].2012,(2).
[6]宋斌斌,陆雪官,钱建军,等.食管癌分次放疗期间靶区不确定性初步研究[J].2009,(3).
[7]高超,王澜,迟子锋,等.食管癌三维适形放疗中摆位误差对剂量学影响的研究[J].2009,(4).
[8]霍俊杰,乔学英,曹彦坤,等.食管胸中段癌三维适形放疗中呼吸运动导致靶区移位的研究[J].2010,(3).
[9]王玮,李建彬,张英杰,等.三维CT与四维CT确定食管癌原发肿瘤内在大体肿瘤体积比较研究[J].2012,(1).
[10]王玮,李建彬,张英杰,等.基于四维CT的胸中下段食管癌大体肿瘤体积和位移的相关研究[J].2012,(2).
[11]曹彦坤,高超,王澜,等.红外线跟踪摆位系统与电子射野影像装置对摆位误差测量结果的比较研究[J].2011,(5).
[12]韩大力,于金明,贾慧,等.放射治疗中食管癌临床靶区确认的争议与共识[J].2012,(1).
[13]李奉祥,李建彬,张英杰,等.四维影像在肿瘤放射治疗中的应用[J].2011,(10).
[14]谢志原,王捷忠,瞿宜艳,等.食管癌图形引导的放射治疗（IGRT）6个自由度摆位误差研究[J].2009,(2).
[15]McNair HA,Tait DM,Hawkins MA,etc.Set-up errors in radiotherapy for oesophageal cancers--is electronic portal imaging or conebeam more accurate?[J].2011,98(2).
[16]Okano Y,Nakagawa K,Tanaka K,etc.Patient setup error and day-to-day esophageal motion error analyzed by cone-beam computed tomography in radiation therapy.[J].2010,49(4).
[17]Nguyen LT,Guerra R,McAleer MF,etc.Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography.[J].2008,70(1).
[18]Yu ZH,Komaki R,Bucci MK,etc.Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction.[J].2007,84(3).
[19]Hawkins MA,Aitken A,Brooks C,etc.Cone beam computed tomography-derived adaptive radiotherapy for radical treatment of esophageal cancer.[J].2010,77(2).
[20]Onoe T,Okuma K,Ito S,etc.Four-dimensional measurement of the displacement of internal fiducial markers during 320-multislice computed tomography scanning of thoracic esophageal cancer.[J].2011,79(2).
[21]Liu A,Pezner RD,Schultheiss TE,etc.Setup variations in radiotherapy of esophageal cancer: evaluation by daily megavoltage computed tomographic localization.[J].2007,68(5).
[22]Chen,Y.-J.,Wong,J.Y.C.,Schiffner,D.C.,etc.Residual setup errors and dose variations with less-than-daily image guided patient setup in external beam radiotherapy for esophageal cancer[J].2012,102(2).
[23]Miyata,H.,Tomiyama,N.,Kato,H.,etc.Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors[J].2012,53(6).
[24]Yock T,Patel AA,Niemierko A,etc.Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer.[J].2009,74(1).
[25]McNair HA,Hawkins MA,Tait DM,etc.Cone beam CT verification for oesophageal cancer - impact of volume selected for image registration.[J].2011,50(8).
[26]Cohen,R.J.,Paskalev,K.,Litwin,S.,etc.Esophageal motion during radiotherapy: Quantification and margin implications[J].2010,23(6).
[27]Langendijk JA,Mul VE,Pruim J,etc.A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer.[J].2010,97(2).
[28]Shimizu S,Shirato H,Ahn YC,etc.Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors.[J].2005,61(5).